SecBot SecBot
SECBOTREPLAY Home › Report › CGON

CGON · CG Oncology announced the departure of President & COO Ambaw Bellete,…

CG Oncology, Inc. · 8-K filed May 26, 2026 at 08:00 ET

At the news

NEUTRALIMPACT 3/10

8-K filed May 26, 2026 at 08:00 ET

CG Oncology announced the departure of President & COO Ambaw Bellete, effective June 30, 2026, and appointed CEO Arthur Kuan as President in addition to his existing roles. The company has initiated a search for a Chief Commercial Officer. This is a routine executive reorganization with no material financial impact.

  • President & COO Ambaw Bellete agreed to separation effective June 30, 2026
  • CEO Arthur Kuan appointed as President in addition to his current positions
  • Company initiated search for a Chief Commercial Officer
  • Bellete will receive severance benefits per existing employment agreement

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access